AN EARLY CLINICAL PHASE-II EVALUATION OF PAROXETINE, A NEW POTENT AND SELECTIVE 5HT-UPTAKE INHIBITOR IN PATIENTS WITH DEPRESSIVE-ILLNESS

被引:35
作者
BORUP, C
MEIDAHL, B
PETERSEN, IM
VANGTORP, A
HONORE, PL
机构
[1] ST HANS MENTAL HOSP, DEPT F, DK-4000 ROSKILDE, DENMARK
[2] HOLBAEK CTY HOSP, DEPT PSYCHIAT, HOLBAEK, DENMARK
[3] BISPEBJERG HOSP, DEPT PSYCHIAT, DK-2400 COPENHAGEN NV, DENMARK
[4] AS FERROSAN, DIV RES, DK-2860 SOEBORG, DENMARK
来源
PHARMACOPSYCHIATRIA | 1982年 / 15卷 / 06期
关键词
D O I
10.1055/s-2007-1019535
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:183 / 186
页数:4
相关论文
共 13 条
[11]   COURSE OF DEPRESSIVE PSYCHOSES [J].
PERRIS, C .
ACTA PSYCHIATRICA SCANDINAVICA, 1968, 44 (03) :238-&
[12]   POTENT DEPLETION OF 5HT FROM MONKEY WHOLE-BLOOD BY A NEW 5HT UPTAKE INHIBITOR, PAROXETINE (FG-7051) [J].
PETERSEN, EN ;
BECHGAARD, E ;
SORTWELL, RJ ;
WETTERBERG, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 52 (01) :115-119
[13]   DECREASED BLOOD LEVEL OF 5-HYDROXYTRYPTAMINE BY INHIBITORS OF MEMBRANAL 5-HYDROXYTRYPTAMINE UPTAKE [J].
ROSS, SB ;
JANSA, S ;
WETTERBERG, L ;
FYRO, B ;
HELLNER, B .
LIFE SCIENCES, 1976, 19 (02) :205-210